Javier Zulueta appointed as Chief Medical Officer at Qure.ai

In a significant move towards expanding its AI lung solutions across U.S. health systems, Qure.ai has announced the appointment of Dr. Javier Zulueta as its new Chief Medical Officer of Pulmonology.

Dr. Zulueta brings a wealth of experience to his new role, having held academic and clinical positions at Mount Sinai hospitals in New York. He was a professor of medicine at the Icahn School of Medicine at Mount Sinai, and the chief of pulmonary, critical care, and sleep medicine at Mount Sinai Morningside Hospital.

With over 30 years of clinical and research experience, Dr. Zulueta has made significant contributions to the field of pulmonology. He has been a principal investigator for Europe's longest-running International Early Lung Cancer Action Program initiative and founded Spain's first lung cancer screening program.

Dr. Zulueta's previous experience in expanding lung cancer screening programs may prove invaluable in Qure.ai's efforts to expand deployments of its AI lung solutions across U.S. health systems.

His appointment at Qure.ai signifies a continued focus on the development and deployment of AI lung solutions. Dr. Zulueta's role is not limited to pulmonology but also involves expanding these solutions across U.S. health systems.

Qure.ai's CEO, Prashant Warier, expressed his excitement about Dr. Zulueta's appointment, saying, "We are thrilled to have Dr. Zulueta join our team. His extensive experience and expertise in lung health will be instrumental in driving the growth of our AI lung solutions in the U.S."

Dr. Zulueta's work has been associated with Qure.ai, and he has previously collaborated with the company on various projects. In his new role, he will advance the clinical strategy behind Qure.ai's AI lung solutions and utilise his expertise in pulmonology to contribute to the improvement of lung health outcomes through AI technology.

The appointment of Dr. Zulueta reflects Qure.ai's commitment to improving lung health through AI technology. With his joining the team, Qure.ai is poised to make significant strides in the field of AI-powered lung health solutions.